Zoe Belle Gender Collective Transfemme is an Australian website designed to promote healthier relationships between trans women and cisgender men. This website has been created by the Zoe Belle Gender Collective in collaboration with a collective of Victorian-based trans women and cis men who have experience in dating or are in relationships with trans women. The content is based on the...
ACON, October 28, 2020 The latest 2020 SWASH report was released on 28th October 2020 as part of a series of Mental Health month events. The SWASH survey is a comprehensive survey of important health issues relevant to lesbian, bisexual, queer and other non-heterosexual identifying women engaged with Sydney’s lesbian, gay, bisexual, transgender, intersex and queer (LGBTIQ) communities. SWASH has...
ANROWS, June 2020 Crossing the line: Lived experience of sexual violence among trans women of colour from culturally and linguistically diverse backgrounds in Australia This research set out to increase understanding of the lived experience of being a trans woman of colour living in Australia, in relation to gender transitioning and experiences of sexual violence. Using a large comparative...
Kota, K.K., Salazar, L.F., Culbreth, R.E. et al. Psychosocial mediators of perceived stigma and suicidal ideation among transgender women. BMC Public Health 20, 125 (2020). Abstract Background Transgender women (TGW) in the U.S. experience high rates of stigma, depression, and elevated rates of suicide. This study examined correlates of suicidal ideation and estimated the conditional indirect...
The Conversation, October 23, 2019 9.25pm AEDT Stigma and discrimination are common experiences that people who identify as LGBT or sexual minority face when accessing health services. One report found that one in seven LGBT people in the UK avoided seeking healthcare for fear of discrimination from staff. As many as one in four also experienced negative remarks against LGBT people from...
aidsmap/nam, November 9th 2018 A study presented at October’s HIV Research for Prevention conference (HIVR4P) in Madrid shows that transgender women who are taking feminising hormones and also taking pre-exposure prophylaxis (PrEP) have levels of the PrEP drugs tenofovir and emtricitabine in their blood that are about 25% lower than those in cisgender men, and levels in rectal tissue cells...